Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models
Lung adenocarcinoma (LUAD), the most common subtype of lung cancer, is a global health challenge with high recurrence and mortality rates. The coagulation cascade plays an essential role in tumor disease progression and leads to death in LUAD. We differentiated two coagulation-related subtypes in LU...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIMS Press
2023-04-01
|
| Series: | Mathematical Biosciences and Engineering |
| Subjects: | |
| Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2023470?viewType=HTML |
| _version_ | 1797830132358971392 |
|---|---|
| author | Mengyang Han Xiaoli Wang Yaqi Li Jianjun Tan Chunhua Li Wang Sheng |
| author_facet | Mengyang Han Xiaoli Wang Yaqi Li Jianjun Tan Chunhua Li Wang Sheng |
| author_sort | Mengyang Han |
| collection | DOAJ |
| description | Lung adenocarcinoma (LUAD), the most common subtype of lung cancer, is a global health challenge with high recurrence and mortality rates. The coagulation cascade plays an essential role in tumor disease progression and leads to death in LUAD. We differentiated two coagulation-related subtypes in LUAD patients in this study based on coagulation pathways collected from the KEGG database. We then demonstrated significant differences between the two coagulation-associated subtypes regarding immune characteristics and prognostic stratification. For risk stratification and prognostic prediction, we developed a coagulation-related risk score prognostic model in the Cancer Genome Atlas (TCGA) cohort. The GEO cohort also validated the predictive value of the coagulation-related risk score in terms of prognosis and immunotherapy. Based on these results, we identified coagulation-related prognostic factors in LUAD, which may serve as a robust prognostic biomarker for therapeutic and immunotherapeutic efficacy. It may contribute to clinical decision-making in patients with LUAD. |
| first_indexed | 2024-04-09T13:31:16Z |
| format | Article |
| id | doaj.art-e48fa808c12f42d696d782d4f89de60b |
| institution | Directory Open Access Journal |
| issn | 1551-0018 |
| language | English |
| last_indexed | 2024-04-09T13:31:16Z |
| publishDate | 2023-04-01 |
| publisher | AIMS Press |
| record_format | Article |
| series | Mathematical Biosciences and Engineering |
| spelling | doaj.art-e48fa808c12f42d696d782d4f89de60b2023-05-10T01:24:04ZengAIMS PressMathematical Biosciences and Engineering1551-00182023-04-01206106261065810.3934/mbe.2023470Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic modelsMengyang Han0Xiaoli Wang 1Yaqi Li2Jianjun Tan3Chunhua Li4 Wang Sheng51. Department of Pharmacology, Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China1. Department of Pharmacology, Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China1. Department of Pharmacology, Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China2. Department of Biomedical Engineering, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China2. Department of Biomedical Engineering, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China1. Department of Pharmacology, Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, ChinaLung adenocarcinoma (LUAD), the most common subtype of lung cancer, is a global health challenge with high recurrence and mortality rates. The coagulation cascade plays an essential role in tumor disease progression and leads to death in LUAD. We differentiated two coagulation-related subtypes in LUAD patients in this study based on coagulation pathways collected from the KEGG database. We then demonstrated significant differences between the two coagulation-associated subtypes regarding immune characteristics and prognostic stratification. For risk stratification and prognostic prediction, we developed a coagulation-related risk score prognostic model in the Cancer Genome Atlas (TCGA) cohort. The GEO cohort also validated the predictive value of the coagulation-related risk score in terms of prognosis and immunotherapy. Based on these results, we identified coagulation-related prognostic factors in LUAD, which may serve as a robust prognostic biomarker for therapeutic and immunotherapeutic efficacy. It may contribute to clinical decision-making in patients with LUAD.https://www.aimspress.com/article/doi/10.3934/mbe.2023470?viewType=HTMLlung adenocarcinomacoagulationunsupervised clusteringrisk scoreimmunotherapycascade |
| spellingShingle | Mengyang Han Xiaoli Wang Yaqi Li Jianjun Tan Chunhua Li Wang Sheng Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models Mathematical Biosciences and Engineering lung adenocarcinoma coagulation unsupervised clustering risk score immunotherapy cascade |
| title | Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| title_full | Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| title_fullStr | Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| title_full_unstemmed | Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| title_short | Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| title_sort | identification of coagulation associated subtypes of lung adenocarcinoma and establishment of prognostic models |
| topic | lung adenocarcinoma coagulation unsupervised clustering risk score immunotherapy cascade |
| url | https://www.aimspress.com/article/doi/10.3934/mbe.2023470?viewType=HTML |
| work_keys_str_mv | AT mengyanghan identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels AT xiaoliwang identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels AT yaqili identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels AT jianjuntan identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels AT chunhuali identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels AT wangsheng identificationofcoagulationassociatedsubtypesoflungadenocarcinomaandestablishmentofprognosticmodels |